Location History:
- Roncade, IT (2016)
- Treviso, IT (2016)
Company Filing History:
Years Active: 2016
Title: Anna Smaniotto: A Pioneer in Pharmaceutical Innovations
Introduction
Anna Smaniotto, hailing from Roncade, Italy, is a notable inventor with a distinguished career in pharmaceutical innovations. With two patents to her name, Smaniotto's contributions have made a significant impact in the field of drug development, particularly in the detection of polymorphs and the preparation of chiral compounds.
Latest Patents
Smaniotto's latest patents showcase her expertise and innovative spirit. The first patent, titled "Method of detecting polymorphs using synchrotron radiation," introduces a groundbreaking technique for identifying specific polymorphs present in small quantities within mixtures of polymorphic compounds. This method leverages X-ray technology produced by a synchrotron source and provides powerful resolution, making it particularly useful in the pharmaceutical industry.
Her second patent, "Process for preparing enantiomerically enriched oxamides," relates to a chiral oxamide useful as an intermediate in the synthesis of dorzolamide. This innovation not only details the preparation of dorzolamide and its hydrochloride salt but also highlights its application as an active ingredient in medications designed for glaucoma treatment.
Career Highlights
Throughout her career, Anna Smaniotto has worked with reputable companies, notably Zetacube S.r.l. and Zach System S.p.a. Her work in these organizations has allowed her to harness her knowledge and skills in developing innovative pharmaceutical solutions.
Collaborations
Anna has collaborated with esteemed colleagues, including Roberto Brescello and Livius Cotarca. These partnerships have fostered a collaborative environment that promotes advancements in research and development within the pharmaceutical sector.
Conclusion
In conclusion, Anna Smaniotto stands as a remarkable figure in the field of innovation, particularly within pharmaceuticals. Her patents represent her commitment to enhancing drug development processes and addressing critical medical needs. With her pioneering methods and collaborative efforts, Smaniotto is sure to leave a lasting legacy in the realm of science and technology.